Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ZNTL Zentalis Pharmaceuticals Inc

4,11

-0,05 (-1,20%)

28 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Zentalis Pharmaceuticals Charts.

Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Zentalis Pharmaceuticals Charts.

News Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
Dienstag 18 Juni 2024 (1 Woche vor) • GlobeNewswire Inc.

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 4 Juni 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 3 Juni 2024 (4 Wochen vor) • Edgar (US Regulatory)

Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Donnerstag 30 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mittwoch 29 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 29 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
Mittwoch 29 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting
Donnerstag 23 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
Dienstag 14 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
Dienstag 7 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Zentalis Pharmaceuticals Inc News-Artikel

DJ Brookfield Global Inf...

DAXglobal Nuclear Energy...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen